Literature DB >> 2268682

Molecular heterogeneity in McArdle's disease.

S M McConchie1, J Coakley, R H Edwards, R J Beynon.   

Abstract

Biopsies were taken from a group of eleven patients with McArdle's disease, a congenital deficiency in muscle glycogen phosphorylase. The biopsies were screened by Western and Northern blotting for phosphorylase protein, phosphorylase-bound pyridoxal-5'-phosphate (the cofactor of the enzyme) and for phosphorylase mRNA. Of the eleven patients, three expressed phosphorylase mRNA at near normal levels and at the expected size. One of these patients also expressed low levels of phosphorylase protein that correlated with a small amount of measurable phosphorylase activity. These data support the contention of molecular heterogeneity in the presentation of this phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268682     DOI: 10.1016/0925-4439(90)90008-d

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Measurement of the turnover of glycogen phosphorylase by GC/MS using stable isotope derivatives of pyridoxine (vitamin B6).

Authors:  R J Beynon; D M Leyland; R P Evershed; R H Edwards; S P Coburn
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

2.  Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.

Authors:  S Baqué; C B Newgard; R D Gerard; J J Guinovart; A M Gómez-Foix
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

3.  Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.

Authors:  Emil Malucelli; Raffaele Lodi; Andrea Martinuzzi; Caterina Tonon; Bruno Barbiroli; Stefano Iotti
Journal:  Dyn Med       Date:  2005-06-06

4.  Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.

Authors:  A Martinuzzi; L Vergani; R Carrozzo; M Fanin; L Bartoloni; C Angelini; V Askanas; W K Engel
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.